Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institution’s or Principal Investigator’s non- compliance with the terms of Section 20, Anti-Corruption, CRO and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Institution has undertaken or third- party agreements that Institution has entered into before termination. 18.4
Appears in 3 contracts
Samples: Clinical Study Agreement, Clinical Study Agreement, Clinical Study Agreement
Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institution’s or Principal Investigator’s non- or Institution’s non-compliance with the terms of Section 20, Anti-Corruption, CRO and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Principal Investigator or Institution has undertaken or third- third-party agreements that Principal Investigator or Institution has entered into before termination. 18.4.
Appears in 2 contracts
Samples: Study Agreement, Clinical Study Agreement
Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institution’s or Principal Investigator’s non- compliance with the terms of Section 20, Anti-Corruption, CRO and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Institution has undertaken or third- party agreements that Institution has entered into before termination. 18.4a.
Appears in 1 contract
Samples: Clinical Study Agreement
Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institution’s or Principal Investigator’s non- compliance with the terms of Section 20Xxxxxxx 00, Anti-CorruptionXxxx- Xxxxxxxxxx, CRO XXX and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Institution has undertaken or third- party agreements that Institution has entered into before termination. 18.4a.
Appears in 1 contract
Samples: Clinical Study Agreement
Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institution’s or Principal Investigator’s non- or Institution’s non-compliance with the terms of Section 20, Anti-Corruption, CRO and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Principal Investigator or Institution has undertaken or third- third-party agreements that Principal Investigator or Institution has entered into before termination. 18.4a.
Appears in 1 contract
Samples: Clinical Study Agreement
Non-Compliance with Anti-Corruption Provision. If CRO or Pfizer terminates the Study because of Institutionthe Health Services Provider’s or Principal Investigator’s non- non-compliance with the terms of Section 20, Anti-Corruption, CRO and Pfizer will not provide any further payment under this Agreement, regardless of any activities that Institution the Health Services Provider has undertaken or third- third-party agreements that Institution has entered into before termination. 18.4.
Appears in 1 contract
Samples: Clinical Study Agreement